Clinical laboratories.
Summary
Existing law provides for the licensure, registration, and regulation of clinical laboratories and various clinical laboratory personnel by the State Department of Public Health. Existing law prohibits the performance of a clinical laboratory test or examination classified as waived under the federal Clinical Laboratory Improvement Amendments of 1988 (CLIA) unless the test or examination is performed under the overall operation and administration of a laboratory director. Existing law defines "laboratory director," for purposes of a clinical laboratory test or examination classified as waived, as any person who, among others, is licensed to direct a clinical laboratory and who substantially meets the laboratory director qualifications under CLIA. This bill would delete the requirement that a laboratory director substantially meet the laboratory director qualifications under CLIA. The bill would instead limit the CLIA qualification requirements to a person serving as the CLIA laboratory director, as defined, in a laboratory that performs tests classified as moderate or high complexity. Existing law authorizes a person licensed as a clinical laboratory bioanalyst or bioanalyst and qualified under CLIA, and other persons licensed in specified clinical specialties, to perform clinical laboratory tests or examinations classified as of high complexity under CLIA and the duties and responsibilities of a laboratory director, technical consultant, clinical consultant, technical supervisor, and general supervisor, within the area of the licensee's specialty. This bill would specify that this authorization extends to a person who is not the CLIA laboratory director under specified circumstances. Existing law requires an applicant for a clinical laboratory bioanalyst's license to meet specified requirements for education and experience, including that the applicant have a minimum of 4 years' experience as a licensed clinical laboratory scientist performing clinical laboratory work embracing the various fields of clinical laboratory activity in a clinical laboratory approved by the State Department of Public Health. This bill would revise the application requirements to provide that an applicant's minimum of 4 years' experience be in a clinical laboratory certified under CLIA. Existing law authorizes the State Department of Public Health to issue specified licenses, including limited clinical laboratory scientist licenses and clinical licenses in specified fields, and establishes application and annual renewal fees for those licenses. Existing law deposits those fees in the Clinical Laboratory Improvement Fund for use, upon appropriation by the Legislature, for regulatory purposes relating to clinical laboratories, blood banks, or clinical laboratory personnel, as provided. This bill would rename the license for clinical molecular biologist as the license for clinical genetic molecular biologist. The bill would apply existing license renewal fees to persons renewing a clinical cytogeneticist's license or clinical genetic molecular biologist's license.
Bill status
signed
all 5 stages cleared
Introduction
Feb 2015
Committee Review
Sep 2015
Assembly Passage
Jun 2015
Senate Passage
Aug 2015
Signed into Law
Sep 2015
Introduced Feb 26, 2015
Signed Sep 28, 2015
Floor votes · Senate Aug 31, 2015 · Assembly Jun 1, 2015
How they voted
35–0
Passed
Total votes 35
Aug 31, 2015
D
Democratic24
100% Yea
R
Republican11
100% Yea
Vote distribution
All Yea
All Nay
Mixed
No data
Full legislative history
Actions timeline
Total actions
31
Key actions
9
Committee
14
Amendments
2
Sep 28, 2015
Signed into law
Approved by the Governor.
legislature
Sep 2, 2015
Lower · Passed
Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 80. Noes 0. Page 2772.).
lower
Aug 31, 2015
Senate · Passed
Senate Vote: pass (35-0)
senate
Aug 31, 2015
Introduced
In Assembly. Concurrence in Senate amendments pending. May be considered on or after September 2 pursuant to Assembly Rule 77.
lower
Aug 17, 2015
Upper · Passed
From committee: Be placed on second reading file pursuant to Senate Rule 28.8.
upper
Jul 14, 2015
Committee
From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on APPR.
upper
Jul 8, 2015
Upper · Passed
In committee: Hearing postponed by committee.
upper
Jul 1, 2015
Committee
Read second time and amended. Re-referred to Com. on APPR.
upper
Jun 30, 2015
Introduced
From committee: Amend, and do pass as amended and re-refer to Com. on APPR. (Ayes 8. Noes 0.) (June 29).
upper
Jun 11, 2015
Committee
Referred to Com. on B., P. & E.D.
upper
Jun 1, 2015
Assembly · Passed
Assembly Vote: pass (74-0-1)
assembly
May 28, 2015
Lower · Passed
From committee: Do pass. (Ayes 17. Noes 0.) (May 28).
lower
May 6, 2015
Committee
In committee: Set, first hearing. Referred to APPR. suspense file.
lower
Apr 27, 2015
Committee
Re-referred to Com. on APPR.
lower
Apr 21, 2015
Committee
From committee: Do pass and re-refer to Com. on APPR. (Ayes 14. Noes 0.) (April 21). Re-referred to Com. on APPR.
lower
Apr 7, 2015
Lower · Passed
In committee: Hearing postponed by committee.
lower
Mar 24, 2015
Committee
Re-referred to Com. on B. & P.
lower
Mar 16, 2015
Committee
Referred to Com. on B. & P.
lower
Feb 27, 2015
Lower · Passed
From printer. May be heard in committee March 29.
lower
1 primary · 1 co-sponsor
Sponsors
Ask Maddy
·
AI policy assistant
Ask Maddy about AB 940
Scope: CA
Hi! I can help you understand AB 940. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline